HSCs-specific delivery of SESN2 reduces α-SMA-labeled activated HSCs and collagen deposition, thereby ameliorating prolonged CCl4- or BDL-induced hepatic fibrosis in mice. This evidence concerns the gene SESN2 and Hepatic fibrosis.